Morgan Keegan Previews NHC 1Q, Anticipates EPS Of $0.72

Morgan Keegan reports that its EPS estimate of $0.72 is the only published estimate and is up from $0.60 in the prior year period. “We continue to view the favorable RUG-IV Medicare rates as a driver to strong earnings growth in 2011 that could exceed our estimates,” Morgan Keegan writes. “National Healthcare Corp. NHC also offers investors a strong balance sheet and a 2.4% dividend yield. NHC realized a nearly 16% sequential increase in its Medicare per diem during the fourth quarter and we expect further improvement, barring any cuts that the Centers for Medicare & Medicaid Services may propose in coming days.” National Healthcare closed Thursday at $46.24.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsHealth CareHealth Care FacilitiesMorgan KeeganNational Healthcare
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!